Results 11 to 20 of about 951,952 (191)
Autoantibodies in systemic vasculitis [PDF]
Systemic vasculitis is a heterogeneous group of disorders characterized by inflammation and necrosis in the vessel wall. The diagnosis of a systemic vasculitis is challenging, because patients usually present a broad spectrum of manifestations that vary according to the predominant size of vessels affected, organs and systems involved, and the extent ...
Alexandre Wagner Silva De Souza
doaj +5 more sources
Pregnancy and Systemic Vasculitis [PDF]
The systemic vasculitides are rare diseases of vessel wall inflammation. They are classified according to the vessel wall size. Systemic vasculitis is usually diagnosed after the fifth decade of life, except Takayasu arteritis and Bechet's disease which can manifest earlier.
Himanshu Pathak, Chetan Mukhtyar
doaj +5 more sources
Systemic vasculitis and headache. [PDF]
Purpose of review Vasculitis refers to heterogeneous clinicopathologic disorders that share the histopathology of inflammation of blood vessels. Unrecognized and therefore untreated, vasculitis of the nervous system or so called neurovasculitides, lead to pervasive injury and disability making these disorder of paramount ...
Younger DS.
europepmc +3 more sources
Plasmapheresis for systemic vasculitis. [PDF]
AbstractSystemic vasculitides include a variety of, and numerous diseases. In 2012, the International CHAPEL HILL Consensus Conference (CHCC2012) led to a major reorganization of the classification of vasculitis, and this is still in wide use today. Although the results of plasmapheresis for individual diseases have been sometimes shown, there are few ...
Fukuoka K +4 more
europepmc +3 more sources
Vasculitis in Systemic Sclerosis [PDF]
Systemic sclerosis (SSc) is a multiorgan connective tissue disease characterized by autoantibody production and fibroproliferative stenosis of the microvasculature. The vascoluopathy associated with SSc is considered to be noninflammatory, yet frank vasculitis can complicate SSc, posing diagnostic and therapeutic challenges.
Kao, Lily, Weyand, Cornelia
openaire +4 more sources
Immunogenicity and safety to SARS-Cov-2 vaccination in patients with systemic vasculitis [PDF]
Background/objectivesPatients with systemic vasculitis faced the risk of severe COVID-19 and high mortality during the pandemic. Although SARS-CoV-2 vaccination mitigates these outcomes, vaccine hesitancy persists, and data on immunogenicity and safety ...
Erika Biegelmeyer +48 more
doaj +2 more sources
The systemic vasculitides are a heterogeneous group of disorders characterized by inflammation of blood vessel walls. They can be classified according to the size of vessel affected and also into primary de novo vasculitides and secondary to other disease processes. Treatments differ and overlap depending on the type of vasculitis.
Jordan, Kelsey M., Cooper, Cyrus
core +5 more sources
The modern therapy of systemic vasculitides: perspectives and challenges [PDF]
Systemic vasculitis is a heterogeneous group of inflammatory diseases, which are classified according to the diameter of the affected vessels. The treatment of systemic vasculitis is no longer empirical, because of increasing number of randomized ...
P I Novikov, A S Zykova, S V Moiseev
doaj +3 more sources
Systemic vasculitis with latent tuberculosis infection and associated factors: a cross-sectional multicenter study [PDF]
Zhong J +8 more
exaly +2 more sources
Voclosporin and the Antiviral Effect Against SARS-CoV-2 in Immunocompromised Kidney Patients
Introduction: Immunocompromised kidney patients are at increased risk of prolonged SARS-CoV-2 infection and related complications. Preclinical evidence demonstrates a more potent inhibitory effect of voclosporin on SARS-CoV-2 replication than tacrolimus ...
Eline J. Arends +14 more
doaj +1 more source

